What's breaking now, across thousands of outlets.
Communication in clinical trials can make or break research and development. Learn how a formal communication plan and a culture of transparency can protect research outcomes.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.
A new study suggests that for people with dark personality traits, problematic social media use is often tied to relationship jealousy.
For decades, pulse oximeters have been among medicine's most familiar instruments. Clip one onto a finger, and within seconds it reports how much oxygen is in your blood, a vital indicator of health.
The trial seeks to evaluate the effectiveness and safety of using psilocybin to treat depression in veterans.
Experts called on healthcare workers to promote breastfeeding and protect parents and children from the commercial milk formula industry’s influences at a panel discussion for World Breastfeeding…
A research team has identified the transcription factor C/EBPγ as a novel regulator that simultaneously promotes epithelial-mesenchymal transition (EMT) and DNA double-strand break repair in lung…
